14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Mon, 20 May 2024

Trading levels for XY6.F

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 132.18 0.558 %
R2 131.97 0.398 %
R1 131.84 0.299 %
Current price: 131.45
Support S1 131.42 -0.0204 %
S2 131.29 -0.119 %
S3 131.08 -0.279 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 132.60 0.87 %
R2 131.60 0.114 %
R1 131.50 0.0380 %
Current price 131.45
Support S1 117.25 -10.80%
S2 115.95 -11.79%
S3 115.50 -12.13%

XY6.F Predictions History

StockInvest.us BE THE FIRST TO PREDICT

The excellent way of becoming a better trader


  • Easy to use
  • Enhance your skills
  • Predict as many as you like
  • Request predictions
  • Gather points
  • Learn to time your buy and sells

I wonder how good you are and if you can beat me?

Now it is your turn to become professional by doing what professionals do - Exercise

Best regards,

Jim - Co-founder of StockInvest.us [ See tutorial video ]

Click to get the best stock tips daily for free!

About Xylem Inc.

Xylem. Aileron Therapeutics, Inc. operates as a clinical stage chemoprotection oncology company in the United States. The company is developing ALRN-6924, which is in Phase 1 trial for solid tumor and lymphoma; Phase 2a clinical trial to treat peripheral T-cell lymphoma; Phase I clinical trial for the treatment of acute myeloid leukemia (AML) and advanced myelodysplastic syndrome (MDS); Phase 1b trial to test the combination of ALRN-6924 and cytarabine,... XY6.F Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT